ClinicalTrials.gov
ClinicalTrials.gov Menu

Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00100906
Recruitment Status : Completed
First Posted : January 7, 2005
Last Update Posted : August 16, 2013
Sponsor:
Collaborators:
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Chiron Corporation
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2006
  Actual Study Completion Date : July 2013